Geneva Glen Capital, a private equity firm headquartered in Chicago, is launching a fund in partnership with Wanxiang America. Adam Schecter has joined Jeff Gonyo to co-lead the fund. GGC will invest in lower middle-market companies (generally under USD100m enterprise value) in the US and Canada, partnering with successful management

Private equity firm Avista Capital Partners has signed a definitive agreement to acquire the Global Auto Care Business from The Clorox Company.  The Global Auto Care Business consists primarily of Armor All and STP, two brands in the aftermarket appearance and performance auto-care segments.  Upon closing of the transaction, veteran

Boston Heart Lab, a provider of diagnostics for patients with heart disease, has closed on a USD10m series C round of financing led by Bain Capital Ventures. The company has also named Susan Hertzberg chief executive officer. Hertzberg is the former president and chief executive of Ipsogen, the North American

AAC Capital Partners, a Northern European mid-market buy-out firm, has agreed to acquire a majority stake in NSL Services Group, a UK outsourced services provider, from 3i. The enterprise value of the transaction is GBP120m (EUR143m), and the existing management team, led by chief executive Mark Underwood, will reinvest in

Axa Private Equity has acquired a six per cent stake in Bravofly, which operates a comparison engine to book flight tickets on low-cost and traditional airlines. Axa Private Equity led a group of private investors which, in aggregate, has acquired approximately 16 per cent of Bravofly’s capital.   Bravofly has

SL Capital Partners, a private equity fund of funds manager, has held the final close of its European Strategic Partners 2008 fund.  The fund was capped at EUR700m, exceeding its original EUR500m target. ESP 2008, SL Capital’s 15th fund of funds, will invest in Western European buyouts, combining primary fund

IBM has entered into a definitive agreement to acquire Netezza, a provider of business analytics based in Massachusetts, in a cash transaction at a price of USD27 per share or at a net price of approximately USD1.7bn, after adjusting for cash. Netezza is expected to expand IBM’s business analytics initiatives

immatics biotechnologies, a biopharmaceutical company developing advanced therapeutic vaccines that are active against cancer, has raised EUR53.8m in a series C financing round. The new funds will allow the company to finance the ongoing development of immatics’ existing pipeline of advanced therapeutic cancer vaccine candidates. In particular, it allows the

Oremex Resources, a Canadian-based exploration company, has proposed a private placement of units at a price of CAD0.09 per unit, for gross proceeds of approximately CAD1,700,000. Each unit will be comprised of one share of the company and one-half of one share purchase warrant. Each whole warrant will be exercisable